Tech Center 1600 • Art Units: 1612 1639 1675 1682 1684
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18184556 | PAIRED-END SEQUENCING | Non-Final OA | ILLUMINA, INC. |
| 17750213 | EFFICIENT RANDOM ACCESS TO DNA-ENCODED DATA | Non-Final OA | MICROSOFT TECHNOLOGY LICENSING, LLC |
| 18361068 | SCALABLE MULTIPLEX DETECTION OF SOMATIC MUTATIONS | Non-Final OA | VANDERBILT UNIVERSITY |
| 19197756 | METHODS FOR CLASSIFICATION OF TISSUE SAMPLES AS POSITIVE OR NEGATIVE FOR CANCER | Final Rejection | Veracyte, Inc. |
| 17688072 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | Non-Final OA | Personalis, Inc. |
| 17820560 | METHODS FOR PROCESSING NUCLEIC ACID MOLECULES | Non-Final OA | 10x Genomics, Inc. |
| 19085379 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | Non-Final OA | Bio-Rad Laboratories, Inc. |
| 17563718 | SYNTHETIC LONG READ DNA SEQUENCING | Final Rejection | UNM RAINFOREST INNOVATIONS |
| 17825346 | Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides | Non-Final OA | New England Biolabs, Inc. |
| 17924425 | POLYNUCLEOTIDE ARRAYS | Non-Final OA | Oxford University Innovation Limited |
| 17641493 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | Non-Final OA | Oxford Nanopore Technologies PLC |
| 17719362 | METHODS AND COMPOSITIONS FOR DELIVERY OF MOLECULES AND COMPLEXES TO REACTION SITES | Final Rejection | Pacific Biosciences of California, Inc. |
| 17464341 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Non-Final OA | Fred Hutchinson Cancer Center |
| 17412105 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Non-Final OA | Fred Hutchinson Cancer Center |
| 17825863 | METHODS FOR SEAMLESS NUCLEIC ACID ASSEMBLY | Non-Final OA | Twist Bioscience Corporation |
| 17913458 | MODIFIED DNA-ENCODED CHEMICAL LIBRARY AND METHODS RELATED THERETO | Non-Final OA | TECHNISCHE UNIVERSITAET DORTMUND |
| 17813364 | SYSTEM AND METHOD FOR NUCLEIC ACID LIBRARY PREPARATION VIA TEMPLATE SWITCHING MECHANISM | Non-Final OA | Kapa Biosystems, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy